by Claudia Li | Jan 5, 2022 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Blog ❯ DiaCarta Enters a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to Develop Cancer Tests based on its Novel XNA Technology FollowFollow...
by Claudia Li | Dec 22, 2021 | GenomeWeb
Diagnostic Developers Pursue SARS-CoV-2 Omicron Assays for Surveillance, Potential Clinical Use FollowFollowFollow Written by Madeleine Johnsonat GenomeWeb Read the article on GenomeWeb Download the article Success! Email Subscribe Early Cancer Detection Will Save...
by Claudia Li | Nov 30, 2021 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Blog ❯ DiaCarta’s Multivariant COVID-19 Test Accurately Detects the Omicron Variant FollowFollow Pleasanton, California, November 30, 2021. DiaCarta Inc., a precision molecular diagnostics...
by Claudia Li | Oct 11, 2021 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ October ❯ DiaCarta and the Scientific World Mourns the Passing of CSO, Michael J. Powell, Ph.D. FollowFollow Pleasanton, California, October 11, 2021. DiaCarta Inc., a precision molecular...
by Claudia Li | Aug 12, 2021 | Press Releases
Press release Home ❯News & Events❯Press Releases❯ You are here ❯ Home ❯ Month ❯ August ❯ DiaCarta Receives CE/IVD for its New COVID 19 Test that Identifies Delta Plus and New Variants FollowFollow Pleasanton, California, August 12, 2021. DiaCarta Inc., a precision...
